<p>Pharmaron Beijing Co. Ltd. held its First Extraordinary General Meeting of 2025 on December 18, 2025. Shareholders approved the appointments of independent non-executive directors and amendments to the Articles of Association. The proposal to increase the registered capital was also approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251218-11960656), on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

03759

300759

<p>Pharmaron Beijing Co. Ltd. held its First Extraordinary General Meeting of 2025 on December 18, where shareholders approved the appointments of independent non-executive directors, amendments to the Articles of Association, and an increase in registered capital.</p>

Pharmaron Beijing Co. Ltd. Held Extraordinary General Meeting